^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
WTX212
i
Other names: WTX212, WTX212A, engineered red blood cell
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Westlake Therap
Drug class:
PD1 inhibitor, Immunomodulator
Related drugs:
1m
Reboot-105: WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody (clinicaltrials.gov)
P1, N=20, Recruiting, Second Affiliated Hospital, School of Medicine, Zhejiang University | Not yet recruiting --> Recruiting
Enrollment open • Combination therapy • Metastases
|
PD-L1 (Programmed death ligand 1) • PD-1 (Programmed cell death 1)
|
WTX212
6ms
A Exploratory Trial of WTX212A Injection in the Treatment of Patients With Advanced Lung Cancer (clinicaltrials.gov)
P1, N=20, Not yet recruiting, Second Affiliated Hospital, School of Medicine, Zhejiang University
New P1 trial • Metastases
|
WTX212
8ms
A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients With Advanced Malignant Tumors (clinicaltrials.gov)
P1, N=44, Not yet recruiting, Zhejiang University
New P1 trial • Metastases
|
PD-1 (Programmed cell death 1)
|
WTX212
Share via
